Acino expands Latin American presence in M8 acquisition

Swiss pharma firm Acino has acquired M8 Pharmaceuticals, a specialty biopharmaceutical company focused on licensing, marketing, and distributing innovative and established medicines in Mexico and Brazil.

Through the acquisition of the Mexico City-based firm - financial terms of which have not been disclosed - Acino will enter the two largest pharmaceutical markets in Latin America, significantly expanding its geographic footprint and strengthening its position in the region.

The deal will also complement Acino’s existing Latin American division, which is based in Panama and operates across eight countries in Central America, the Caribbean, and Ecuador.